Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase 1/2 2Phase 4 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Lung Neoplasms 3Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Suspected Central Nervous System Tumors 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Rectal Neoplasms 1Multiple Pulmonary Nodules 1Lymphedema 1Head and Neck Neoplasms 1Head and Neck Carcinoma 1Giant Cell Tumor of Bone 1Colorectal Neoplasms 1Chylothorax 1Breast Neoplasms 1

Interventions

pembrolizumab 44Nivolumab 29Gemcitabine 28Paclitaxel 19Cisplatin 18Ipilimumab 15Carboplatin 14Cyclophosphamide 13Capecitabine 12Dexamethasone 10Bevacizumab 10cemiplimab 9Irinotecan 9Docetaxel 9Albumin-Bound Paclitaxel 9130-nm albumin-bound paclitaxel 9spartalizumab 8Pemetrexed 8Sorafenib 7Rituximab 7Cetuximab 7fludarabine 6Temozolomide 6Taxes 6Radiotherapy 6Leucovorin 6Fluorouracil 6Azacitidine 6Ascorbic Acid 6lenvatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms × Indocyanine Green × Clear all
NCT04723810 2026-03-09

TumorGlow Intraoperative Molecular Imaging (IMI)

University of Pennsylvania

Phase 1/2 Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT02946021 2019-04-09

Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema

Tactile Medical

Phase 1/2 Completed
11 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms, Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡